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Effect of Colch icine on the Uptake of Prolactin and
Insulin into Golgi Fractions of Rat Liver
In previous studies we have identified intracellular (Golgi)
receptors for insulin and prolactin and have shown that their
characteristics are similar to those of plasmalemma receptors
(5, 34, 35, 38) . We have also observed that 12'I-ovine prolactin
(125I-oPRL) and 1251-insulin are taken up by rat liver in vivo by
a receptor-mediated process and concentrated in intact form in
Golgi elements (6, 17, 37) . These observations of receptor-
mediated uptake of hormone have suggested that internaliza-
tion proceeds via adsorptive endocytosis .
The secretion of plasma proteins via the Golgi apparatus of
rat liver has been described (3, 14, 32, 39) . Colchicine has been
shown to inhibit the secretory process in liver (2, 10, 39-41)
and other tissues (15, 20, 21, 30, 31, 47) . It has been shown to
have a disorganizing effect on Golgi structure in certain tissues
(44) and to inhibit endocytosis in chondrocytes (33), fibroblasts
(45), and macrophages (44) . Because of these observations of
colchicine's effects on the Golgi apparatus and endocytosis we
have examined the effect of colchicine on the internalization
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ABSTRACT In previous studies we have shown that 1251-labeled prolactin is taken up by a
receptor-dependent process and concentrated in an intact form in Golgi elements from female
rat liver (J . Biol . Chem ., 1979, 254:209-214) . In this study we have examined the effect of
colchicine on this uptake process into Golgi elements . Colchicine [25 iumol (10 mg)/100 gm
body wt] was injected intraperitoneally in adult female rats, and hepatic Golgi fractions were
prepared at 1, 2, and 3 h postinjection . The enzyme recoveries and morphological appearance
of fractions from colchicine-treated and control (alcohol alone) animals were similar. At times
>1 h after colchicine there was a marked (>60%) inhibition of uptake of 1251-ovine prolactin
('25 1-oPRL) into Golgi light and intermediate fractions but no inhibition of uptake into Golgi
heavy and plasmalemma elements . At times from 2 to 45 min postinjection, 125 1-oPRL was
extracted from Golgi elements and found to be largely intact as judged by rebinding to
receptors . The inhibitory effect of colchicine was seen at doses ranging from 0.25 Umol to 25
ttmol/100 g body wt . Vincristine also inhibited 1251-oPRL uptake into the Golgi light and
intermediate fractions but lumicolchicine had no inhibitory effect.
There was a smaller effect of colchicine both at early (1 h) and later (3 h) times on the extent
and pattern of 1251-insulin uptake . Colchicine treatment did not produce a significant change
in lactogen receptor levels in the Golgi fractions . These results demonstrate that colchicine
treatment inhibited the transfer of prolactin into Golgi vesicular elements . The much smaller
effect on insulin uptake suggests that there may be differences in the manner in which the two
hormones are handled in the course of internalization .
of " 5I-labeled insulin and prolactin- Our studies have demon-
strated that colchicine treatment markedly inhibited the uptake
of 125I-oPRL and, to a lesser extent, "'I-insulin into Golgi
vesicular elements [Golgi light (GI) and Golgi intermediate
(Gi)] . The inhibition of "'I-oPRL uptake was not associated
with a reduction of lactogen receptor levels in the Golgi
fractions .
MATERIALS AND METHODS
Animals
Young adult female Sprague Dawley rats of 9-11 wk of age (180-200 g in
weight) were used in these studies . They were fed Purina Chow and caged in
groups of two to four animals.
Reagents
Porcine crystalline zinc insulin (24.4 U/mg) was a gift from Connaught
Research Laboratories, Willowdale, Ontario. Ovine prolactin (oPRL, NIH P-S,
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0021-9525/82/06/0560/08 $1 .0026.4 U/mg) was generously provided by the Pituitary Hormone Distribution
Program of National Institute of Arthritis, Metabolic, and Digestive Diseases,
Bethesda, MD. Carrier-free [ 1Z5í]iodine and UDP-galactose (U-"C) (209 mCi/
mmol) were obtained from New England Nuclear Corp., Boston, MA.
Colchicine, vincristine sulfate (grade II), andovomucoidwere purchasedfrom
the Sigma Chemical Co., St. Louis, MO . Lumicolchicine was prepared from
colchicine byUV irradiation (48) . Colchicine was dissolved (10 mg/ml) in 100%
ethanol, and the solution was placed in tightly sealed vials 3 cm from a 30-watt
UV light. At regular intervals theUV spectrum ofthe solution was obtained and
the disappearance ofcolchicine's absorption maximum at 350 nm was followed.
After 10 h ofirradiation, thishadreached astable minimumsothat the estimated
residual colchicine was <5% of the original amount. The solution was taken to
dryness in vacuo. Colchicine, lumicolchicine, and vincristine were dissolved in
0.9% sodium chloride .
Iodination of insulin and prolactin was done at room temperature using
chloramine-T as described previously (34) .
Uptake of Labeled Hormone in Vivo
Rats were starved overnight and given ethanol (50% vol/vol) by stomach tube
(1 .2 ml/100gm body wt) 90 min before sacrifice (4)except where noted otherwise
(Table I). Experimental animals received an intraperitoneal injection ofa freshly
prepared solution ofcolchicine (25 Itmol (10 mg)/100 g body wt) 3 h before the
injection oflabeled hormone unless specified otherwise (see Fig. l and Table II) .
Control animals were injected with 0.9% saline . The injection oflabeledhormone
was performed in animals lightly anesthetized with ether. The liver was exposed
through a midline incision, and `I-oPRL or "I-insulin (12 .5 x 10' cpm) was
injected in a 0.4-ml volume of 1% bovine serum albumin (BSA)-phosphate
buffered saline via the portal vein. Animals were sacrificed by decapitation 10
min after the injection of ' 25í-oPRL except in the time course studies depicted in
Figs . 2 and 3 . Livers were rapidly excised, placed in ice-cold 0.25 M sucrose, and
TABLE I
Effect of Ethanol and Colchicine Treatment on the Protein
Yield of Different Subcellular Fractions
Protein
mglgm liver
Ethanol
Colchicine
Homogenate
Microsomes
GI
Gi
Gh
￿
1.8±0 .4 1 .9±0.0 1 .910 .2 1.8±0.0
Smooth micro- 13.7±3 .0 11 .5±0.2 13.2±0 .4 14.6±0.0
somes
Rough micro- 10.7±0 .4 10.3±1 .1 10.4±0 .5 13 .7±0.9
somes
Colchicine and ethanol, when administered, were given 3 h and 90 min,
respectively, before sacrifice as described in Materials and Methods . For each
of the four conditions studied, two animals were used . Each value is the mean
t one-half the range of the two separate fractionations .
TABLE II
homogenized for the preparation of Golgi fractions or plasmalemma asdescribed
in detail elsewhere (5). Labeled fractions were counted in duplicate in a model
3002 Auto Gamma scintillation spectrophotometer (Packard Instrument Co .,
Downers Grove, IL) at an efficiency of40%with a counting errorof<2% . Protein
was determined by the procedure of Lowry et al. (22) with BSA as standard.
Enzymatic Characterization of Golgi Fractions
Enzymes were assayed using previously published methods. 5'-Nucleotidase
(EC 3 .2 .2 .4) was determined by the method of Heppel and Hilmoe (16). Acid
phosphatase (EC 3.1 .3 .2) was determined using paranitrophenyl phosphate as
substrate as described by Baldijao et al. (l) with 0.1% wt/vol Triton X-100 in the
final reaction mixture. Glucose 6-phosphatase (EC 3 .1 .3 .9) was measured by the
methodofParkesand Thompson (29) . Succinic aciddehydrogenase(EC 1 .3.99 . I )
was assayed by themethod of Bernath and Singer (7) in the direction ofsuccinate
oxidation using triphenyl tetrazolium chloride as an acceptor dye . After the
reaction was stopped with glacial acetic acid, the colored formazone formed was
extracted with toluene and the absorbance was read at 495 nm in a BeckmanDK
2A spectrophotometer (Beckman Instruments, Inc ., Palo Alto, CA) . Inorganic
phosphate was determined by the method of Chen et al. (12) .
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FIGURE 1
￿
Inhibition by colchicine of 1251-oPRL uptake into rat liver
homogenate and subcellular fractions as a function of time after
colchicine injection . Rats were injected with colchicine (25 pmol/
100 g body wt) at the noted times before sacrifice . All animals
received ethanol 90 min and '251-oPRL by injection 10 min before
sacrifice . Data are the mean t SE of three different experiments in
each of which three to six rat livers were pooled for fractionation as
noted in Materials and Methods . Uptake into whole microsomes
(O) and Golgi light (GI, L), intermediate (Gi, "), and heavy (Gh,
O) subfractions is depicted .
Effect of Colchicine, Vincristine, and Lumicolchicine on the Uptake of ' 251-oPRL into Hepatic Subcellular Fractions
0
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Rats received colchicine [0.25 pmol (0 .1 mg), 1 .25 Irmol (0 .5 mg), 12.5 Amol (5 .0 mg)/100 g body wt]; lumicolchicine [1.25 Iamol (0 .5 mg)/100 g body wt], or
vincristine sulfate [1.25 Amol (1 .15 mg/100 g body wt]), and ethanol 3 h and 90 min, respectively, before the injection of ' 251-oPRL as described in Materials and
Methods . 10 min after ' 251-oPRL injection, the animals were sacrificed and their livers subjected to subcellular fractionation . The nuclear-mitochondrial pellet
(NMP) was obtained by centrifugation of the homogenate at 10,000 ge. for 10 min . Whole microsomes were prepared from the NMP supernatant as described
elsewhere (5) . Supernatant refers to the microsomal supernatant . Control animals were handled identically . The radioactivity (cpm/mg protein) in the subcellular
fractions from drug-treated rats was expressed as a percent of that in corresponding fractions from control animals . All values are the mean ± SE of two or three
different fractionation studies in each of which three to six control and drug-treated animals were used .
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34.0 ± 0.7 32 .1 ± 0 .7 31 .4 ± 2 .2 30 .9 ± 0.4
0.1 ± 0 .0 0 .3 ± 0.0 0 .3 ± 0 .0 0.4 t 0.1
0.4 t 0.0 0 .5 ± 0 .1 0.6 ± 0 .0 0 .7 t 0.1
Drug
,umol/ 100 g
treatment
body wt
Homogenate
1251-oPRL uptake,
NMP
% control
Microsomes Supernatant
Colchicine 0.25 71.91 6 .0 93 .5± 9 .2 80.7±7 .9 69.2±6.1
1 .25 68.8 ± 6 .6 99.3111 .5 67.8±8 .1 60.7±7 .4
12.50 60.6 1 4 .9 90.41 6 .4 64.5±6 .3 51.5±3 .2
Lurnicolchicine 1 .25 104 .8 ± 11 .4 108.5±11 .0 110.9±9 .7 139.1 25 .6
Vincristine 1 .25 79.4 ± 10 .4 97.6±19.4 72.9±9 .8 73 .4 14.6Y x
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FIGURE 2 Effect of colchicine on the time course of 1251-oPRL
uptake into Golgi fractions . Colchicine and ethanol were given 3 h
and 90 min, respectively, before the intraportal injection of 1251-
oPRL . Each time point represents a fractionation on three pooled rat
livers for both control (") and colchicine-treated (O) animals .
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FIGURE 3
￿
Effect of col-
chicine on the associa-
tion of 1251-oPRL with a
plasma membrane frac-
tion . The experiment
was conducted as
noted in the legend of
Fig . 2 . Each point rep-
resents one fractiona-
tion on two pooled fe-
male rat livers from
either control (" ) or
colchicine-treated (O)
animals.
Galactosyl transferase (UDP-galactose:ovomucoid transferase) activity was
determined using ovomucoid (trypsin inhibitor, Sigma Chemical Co.) as the
galactose acceptor (8) . 0.1 ml of reaction mixture contained 40 mM cacodylate
buffer pH 6.6, 40mM magnesium chloride, 40 mM mercaptoethanol, 175 Pg of
ovomucoid, 5 mM ATP, 0.2% (wt/vol) Triton X-100 and 0.1 pCi of UDP-
galactose (U- 1'C) along with unlabeled UDP-galactose to bring the final specific
activity to 0.95 Ci/mmol . Afteraddition of subcellular fraction (protein up to 150
fig), the mixture was incubated at 37'C for 60 min . I ml ofice-cold I% (wt/vol)
phosphotungstic acid in 0.5 N HCIwas added to stop the reaction . After 15 min
at 4°C, the tubes were centrifuged at 3,000rpm for 15 min. Pellets were washed
twice with 5% (wt/vol) ice-cold TCA, once with 1 ml of ethanol:ether (l :1), and
finally dissolved in I ml of2Mammonium hydroxide. This was neutralized with
glacial acetic acid andwas transferred to scintillation vials which contained 15 ml
of Instagel (Packard Instrument Co.) . Counting was done in a refrigerated liquid
scintillation spectrometer (Packard Tricarb, model 3375) at an efficiency of89% .
Suitable enzyme controls were run with each assay by adding membranes to the
reaction mixture after stopping the reaction. Specific activity was expressed as
nmol ofgalactose transferred/60 min permg of protein.
The integrity of "'I-oPRL found in the various subcellular fractions of liver
after in vivo injection was evaluated by extracting the radioactivity and deter-
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mining its capacity to rebind to lactogen receptors. 1251-oPRL was extracted with
0.01 NHCI containing 1% BSA by incubating on a shaker at 4°C for 16 h . The
suspension was centrifuged at 100,000g., for 60 min . An aliquot ofsupernatant
was countedto determine the percentradioactivityextracted . After neutralization
with dilute sodium hydroxide, an aliquot was chromatographed on Sephadex G-
100 to check the molecular weight of the extracted material . Another aliquot was
tested for binding to female rat liver microsomes. Controls were run in which
freshly prepared 1s .í-oPRL was treated in the same way.
Determination of Specific Binding
Microsomes and Golgi fractions were frozen and thawed four times before
using in binding assays (38) . Plasmalemma was frozen and thawed once only
(38) . Labeled hormone (5-10 x 10' cpm) was incubated in triplicate with 50 jig
of Golgi or plasmalemma fraction in a final 0.5-ml volume containing 25 mM
Tris-HCI, 10 mM magnesium chloride, and 0.1% (wt/vol) BSA, pH 7.4. Incuba-
tions were done at 4'C for 48 h (34, 35). Parallel incubations were done in the
presence of excess hormone (5 pg) . After completion of the incubation, the
reaction mixture was diluted with 3 ml of ice-cold Tris-Mg-BSA buffer, and
bound hormone was separated from free by centrifugation at 3,000 rpm for 20
min. Specific binding is defined as the difference between radioactivity bound in
the absence (total binding) and that bound in the presence (nonspecific binding)
ofexcess unlabeled hormone and is expressed as a percent ofthe totalradioactivity
in the incubation.
Radioautography
Animals were handled as described above except that they received 180-210
x 106 cpm of 12Sí-oPRL at 10 and 30 min before sacrifice. Portions of freshly
prepared Golgi fractions were briefly fixed with 2% glutaraldehyde/0.I M
cacodylate buffer and processed for radioautographic analysis as described in
detail previously (17) .
RESULTS
Influence of Colchicine Treatment on the Yield
and Purity of Golgi Fractions
The recovery of the different subcellular fractions (yield of
protein) as a function of treatment with ethanol and/or col-
chicine is summarized in Table I. Colchicine alone had an
effect comparable to that of ethanol alone . The combination of
colchicine and ethanol administration produced a minimal
increase in the yield obtained with either agent alone .
The yield and purity of the Golgi fractions from colchicine-
treated rats was evaluated by examining the Golgi marker
enzyme, galactosyl transferase (4) . The assay employed was
based on the procedure in which ovomucoid, an oviduct gly-
coprotein with terminal N-acetylglucosamine residues, was
used as an acceptor of galactose from UDP-galactose (8) . We
obtained recoveries of 29.4 and 33.4% of homogenate activity
in the total Golgi elements form control and colchicine-treated
rats, respectively (Table III) . The specific activity and relative
specific activity of galactosyl transferase in the subcellular
fractions from both control and colchicine-treated rats were
comparable except for lower activity in the GI from the latter.
In the experiment ofTable III, the overall recovery of homog-
enate galactosyl transferase activity was 100.7% for control and
107.3% for colchicine-treated animals.
The relative specific activities and recoveries of typical
marker enzymes, 5'-AMPase, glucose 6-phosphatase, acid
phosphatase, and succinic dehydrogenase for plasmalemma,
endoplasmic reticulum (ER), and lysosomal and mitochondrial
elements are summarized in Table IV . Colchicine treatment
did not change the relative specific activity or the recovery of
any enzyme activity from that seen in control animals. The
recovery of homogenate activity in the generated fractions for
control and colchicine-treated rats, respectively was : 5'-nucle-
otidase, 98.2% and 92.7%; glucose 6-phosphatase, 131 .6% and
131 .9% ; acid phosphatase, 104.9% and 96.8% .Effect of Colchicine, Lumicolchicine, and
Vincristine Treatment on the Hepatic Uptake
of
1251-oPRL
In early studies we noted an inhibitory effect of colchicine
on the uptake of 1251-oPRL into Golgi fractions. In Fig. 1, the
effect of colchicine on 1251-oPRL uptake was examined as a
function of time after injection of the drug . The inhibition of
uptake into GI was noted by 1 h after colchicine, whereas that
into Gi was not seen until 2 h postinjection . There was no
effect on uptake into Golgi heavy (Gh) at early times postin-
jection, but by 3 h there was an increase of radioactivity inGh
with levels reaching -150% that of controls. Uptake into
microsomes was inhibited in a fashion parallel to, though less
marked than, uptake into Gi . In all subsequent studies we have
TABLE III
Effect of Colchicine Treatment on Yield and Purity of
Galactosyl Transferase Activity in Hepatic Subcellular
Fractions
Control rats
Homogenate
Microsomes
G I
Gi
Gh
Smooth micro-
somes
Colchine-treated
rats
Homogenate
Microsomes
GI
Gí
Gh
Smooth micro-
somes
Colchicine and ethanol were given 3 h and 90 min, respectively, before
sacrifice as described in Materials and Methods . Control animals received
ethanol only . The livers from three control and three colchicine-treated rats
were respectively pooled for homogenization and subsequent fractionation.
Galactosyl transferase assays were done on freshly prepared fractions and
specific activity was nmol galactose transferred/60 min per mg of protein as
described in Materials and Methods . Relative specific activity is the ratio of
the enzyme specific activity in a subcellular fraction to that in the whole
homogenate.
Effect of Colchicine, Lumicolchicine, and Vincristine on the Uptake of 1251-oPRL into HepaticMicrosomal Subfractions
TABLE V
examined 1251-oPRL uptake at 3 h after drug injection.
The effect of three doses of colchicine and one dose each of
lumicolchicine and vincristine on the uptake of 1251-oPRL into
whole liver homogenates and subcellular fractions was exam-
ined (Table II) . Colchicine inhibited uptake into liver asjudged
by levels of radioactivity in liver homogenate . Inhibition was
more marked at a dose of colchicine of 12 .5 p,mol/ 100 g body
wt than at one of 0.25 ,umol/100 g body wt. Examination of
subcellular fractions indicated no significant inhibition by col-
chicine of uptake into the nuclear-mitochondrial pellet (NMP)
but readily observable inhibition ofuptake into the microsome
and microsomal supernatant fractions . Vincristine produced a
pattern of inhibition comparable to that of colchicine whereas
lumicolchicine was without inhibitory effect.
We then examined the effect of colchicine, lumicolchicine
and vincristine on the uptake of 1251-oPRL into microsomal
subfractions (Table V). Colchicine and vincristine inhibited
1251-oPRL uptake into GI and Gi. Some inhibition of uptake
into rough microsomes was also observed . There was no effect
on uptake into Gh but uptake into this fraction was highly
variable as reflected in the large standard errors. Inhibition of
uptake was seen at a dose of colchicine as low as 0.25 p.mol/
100 g body wt . Lumicolchicine was without an inhibitory effect
on uptake into any of the fractions and actually stimulated
uptake into GI (P < 0.01). Subsequent studies have been
carried out with colchicine at a dose of25 pmol/100 g body wt .
Succinic dehydrogenase
￿
ND
￿
ND
Rats received colchicine and ethanol or ethanol alone (control) as described
in Materials and Methods . Three colchicine-treated and three control animals
were sacrificed and their livers were pooled respectively and homogenized .
The individual Golgi fractions, isolated as described before (1), were pooled
to yield a total Golgi fraction and assayed for the denoted enzymes as
described in Materials andMethods . Relative specific activity was determined
as noted in the legend of Table III . The numbers in parentheses refer to
percent recovery . ND, none detected .
Rats received colchicine, lumicolchicine, or vincristine sulfate and ethanol 3 h and 90 min, respectively, before the injection of 1251-oPRL . Whole microsomes
were prepared and subfractionated as described previously (5) . The experimental procedure was as described in the legend of Table II . All values are the mean
±SE of three or four different studies in each of which three to six control and drug-treated animals were used .
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148.60 882.6 5.9 1 .0 100 TABLE IV
40.20 606.3 15 .1 2.5 68 .7
0.25 48 .5 197.1 33 .2 5.51
The Relative Specific Activity andRecovery of VariousMarker
0.42 70 .9 168.5 28 .4 8.0 29 .4 Enzymes in Total Golgi Elements from Colchicine-treated and
2.11 140.6 66 .5 11 .2 15 .9
Control Rats
12.50 252.0 20 .1 3.4 28 .5 Relative sp act
Enzymes Control Colchicine
178.30 793.6 4.5 1.0 100 5'-Nucleotidase 3.2 3.7
48.30 519.0 10 .7 2.4 65.4 (6 .0) (6.4)
0.31
0.48
32 .3
82 .0
105.5
172.2
23 .7
38 .7 10.3
19.01
4.,~
33.4
Glucose 6-phosphatase 1 .9 2.0
2.34 150.8 64 .5 14.5 (3 .5) (3.5)
15.90 249.3 15.7 3.5 31.4 Acid phosphatase 1 .6 2.0
(3 .0) (3.5)
'251-oPRL uptake, % control
Smooth Rough
Drug treatment GI Gi Gh microsomes microsomes
pmol/100 g body wt
Colchicine 0.25 34 .8 ± 4.3 64 .6 ± 5.5 74 .3 t 13.9 86 .1 ± 6.6 83 .3 ± 8.8
1.25 18 .4 ± 3.2 46 .5 ± 5.0 111.9±19.8 85.7±14.1 75.7±9.0
12.50 19 .3 ± 5.0 34 .8 ± 6.4 84.1±11.4 70.5±8.9 74.7±12.5
25.00 23 .3 ± 6.5 34 .6 ± 4.7 100.4 t 24.7 100.3 ± 4.1 68 .0 ± 20.5
Lumicolchicine 1.25 151 .3 ± 15 .5 99 .7 ± 7.8 104.5±18.1 106.4±14.4 107.9±8 .3
Vincristine 1.25 28 .4 ± 4.7 40 .0 ± 6.0 86.4±13.4 63.1±3.0 66.2±7 .8
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FIGURE 4 Effect of colchicine on the time course of '251-insulin
uptake into Golgi fractions . Experimental protocol was the same as
noted in the legend of Fig . 2 . Each time point represents a fraction-
ation on three pooled rat livers from both control (") and colchi-
cine-treated (O) rats .
Effect of Colchicine on the Time Course of
Uptake of 1251-oPRL
The time course of 1z5í-oPRL uptake into Golgi fractions
was compared in control and colchicine-treated rats (Fig . 2) .
Uptake into GI and Gi was inhibited at times earlier than 45
min after 1261-oPRL administration . Colchicine inhibited the
uptake of 1261-oPRL by 77 and 62% in GI and Gi, respectively,
at 15 min, the peak of 1251-oPRL uptake in control rats .
Colchicine treatment appeared to cause some accumulation of
radiolabel in Gh at times >15 min after 1Z5í-oPRL injection
(Fig. 2) . At earlier times no such difference between control
and colchicine treatment was noted . A second experiment
performed in a manner identical to that depicted in Fig. 2
resulted in similar observations. Thus, the uptake of 1261-oPRL
was inhibited by 77% in GI and 64% in Gi by 15 min postin-
jection . Again, no inhibition of uptake into Gh was observed
and indeed some accumulation above control was noted at
times 15 min postinjection . Colchicine treatment had minimal,
ifany, effect on the uptake of 1261-oPRL into a purified plasma
membrane fraction (Fig . 3) .
Effect of Colchicine Treatment on the Hepatic
The effect of colchicine treatment (25 pmol/ 100 gm body
wt) on the time course of uptake of 1251-insulin into Golgi
fractions was also studied (Fig . 4) . Inhibition of uptake was
observed in all three fractions at early times (<_10 min), with
the inhibition being most consistent and marked at 2 min after
1261-insulin. In general, the inhibitory effect on uptake into GI
and Gi was ofmuch shorter duration than that observed with
1261-oPRL . These observations were confirmed in a second,
comparable study .
564
￿
THE JOURNAL OF CELL BIOLOGY " VOLUME 93, 1982
TABLE VI
Effect of Colchicine on the Extraction and Integrity of
1251_
oPRL Taken up by Rat Liver Subcellular Fractions
Specific binding, %uninjected ' 261-oPRL
Time
after
￿
Smooth
injec-
￿
micro-
Rats received colchicine and ethanol or ethanol alone (control) and were
injected with '251-oPRL and sacrificed, after which the subcellular fractions
were obtained and extracted for their contained radioactivity as described in
Materials andMethods . The extracted radioactivity was evaluated for integrity
on the basis of its ability to rebind to female rat liver microsomes . Data are
specific binding expressed as a percent of that of uninjected 1251-oPRL . Values
in parentheses are the percent of radioactivity extracted from each subcellular
fraction .
Integrity of 1251-oPRL Taken up by the Hepatic
Subcellular Fractions
The effect of colchicine treatment (25 pmol/100 gm body
wt) on the integrity of í25I-oPRL as evaluated by rebinding of
extracted radioactivity to female rat liver microsomes is de-
picted in Table VI . There was no systematic difference attrib-
utable to colchicine in either the extractability or integrity of
the radiolabeled hormone . In both control and colchicine-
treated rats, the radioactivity extracted from both smooth
microsomes and Gh was intact at all times examined . In fact
the extracted radioactivity showed superior binding to receptor
than that seen with fresh uninjected
126
1-oPRL, suggesting a
selective concentration of intact molecules in these fractions
with a corresponding failure to take up less intact ("damaged")
12sí-oPRL.' In GI and Gi, the degree of integrity was less than
that of control 1251-oPRL but remained remarkably level over
the 2- to 30-min time range of this study . Radioactivity asso-
ciated with smooth microsomes was substantially less extract-
able than that from other subcellular fractions . Radioactivity
from rough microsomes was <_35% the integrity of uninjected
1261-oPRL at all times studied (data not shown) and accounted
for only a small fraction of the total radioactivity taken up by
microsomes (17) .
Effect of Colchicine Treatment on Binding of
1251-oPRL and 125 1-Insulin to Subcellular
Fractions from Female Rat Liver
The effect of colchicine treatment on the specific binding of
1Z5
í-oPRL and 1261-insulin to subcellular fractions from rat liver
is depicted in Table VII. Fractions obtained 1 and 3 h after
colchicine treatment show levels of specific binding similar to
' Some ofthe 1251-oPRL may have undergone chemical damage in the
course ofpreparation rendering it less able to bind to receptors .
450T tion Treatment GI Gi Gh somes
min
Gi 2 Control 104.2 83 .3 100.2 113.4
a . 300
U
O
(100) (84.7) (75.9) (60.1)
w
á
O
+ Colchicine 122.9 57 .7 109.4 162.7
150 (100) (93.6) (78.9) (56.9)
10 Control 81 .7 73 .4 155.4 137.6
z (83.4) (91 .5) (78.9) (57.8)
+ Colchicine 77 .1 79.0 111.4 126.4
z 150T (98.0) (90.6) (81.1) (46.5)
Gh 30 Control 106.4 74.4 126.2 134.7
75 (86.7) (83.9) (98.1) (60.9)
+ Colchicine 94 .7 89.7 145.4 160.0
(100) (79.1) (93.0) (49.1)TABLE VII
Effect of Colchicine Treatment on the Specific Binding of 1251-oPRL and 12 5 1-Insulin to Various Subcellular Fractions
FIGURE 5
￿
Electron microscope radioautographs of Gi (a and b) and
Ch fraction (c-e) at 10 and 30 min, respectively, after injection of
'251-oPRL into colchicine-pretreated rats . Silver grains (arrows) were
foundmainly (71%)over lipoprotein-filled (LP) vesicularand tubular
structures in the Gi fraction (a and b) but over small tubular
structures (t) in the Gh fraction (c and e), with fewer grains over
vesicular (v) elements (d) . Quantitative analysis carried out on the
Gh fraction at 10 min and 30 min after hormone injection revealed
61% and 58.4%, respectively, of the total grains (369 and 243,
respectively) over tubular structures with 18 .4 and 28.4%, respec-
tively, over vesicular structures . Forcontrol animals, 53%of the silver
grains were observed over small empty tubular structures in the Gh
fraction . (a) x 25,000; (b-e) x 38,000 .
that of fractions from control animals . Two exceptions are the
higher specific binding of 1251-insulin in Gi from colchicine-
treated compared with control animals, and the higher specific
binding of 1251-oPRL in Gi and Gh from animals 1 and 3 h,
Rats received colchicine for 1 or 3 h and ethanol for 90 min before sacrifice . Control animals received ethanol alone . Subcellular fractions were prepared and
specific binding determined as described in Materials and Methods . Each value is the mean t one-half the range of two different experiments in each of which
three rat livers were pooled for colchicine -treated and control rats, respectively, Nonspecific bindingwas 6-12% for ' 251-oPRL and4-9% for '251-insulin .
respectively, after colchicine treatment compared with control
animals. In particular, colchicine treatment had no significant
effect on 1z5í-oPRL binding in GI and Gi prepared 3 h after
the drug was givenwhen uptake into these fractions was greatly
inhibited (Fig. 1) .
Electron microscope radioautography was performed on Gh
fractions isolated 10 and 30 min after the injection of 1251-oPRL
to control and colchicine-treated rats . We observed the same
distribution of grains between flattened saccules and small
vesicles from colchicine-treated and control rats (Fig. 5) .
DISCUSSION
The data ofTable I indicate that colchicine treatment increased
the yield of the GI fraction in a manner similar to ethanol
pretreatment . The effect on the yield of the other subcellular
fractions appeared to be minimal . This differs from the obser-
vation ofOda et al . (25) who showed that colchicine pretreat-
ment increased the yield of all the hepatic Golgi fractions
compared with the yield from both ethanol-treated and un-
treated rats . In agreement with Oda et al. is our observation of
lower levels of galactosyl transferase in the GI fraction from
colchicine- vs . ethanol-treated rats (Table III) . This does not
seem to be due to contamination of the GI fraction by other
subcellular elements, since morphologic studies have attested
to the similarity of hepatic Golgi fractions from colchicine-
treated and control animals at both low (25) and high (39)
doses of the drug . In addition, the enzymatic characteristics of
fractions from colchicine-treated animals closely resembled
those from controls, except for reduced levels of galactosyl
transferase in the Golgi light fraction from the former . The
recent demonstration of colchicine binding to Golgi fractions
and its inhibition of galactosyl and sialyl transferase activities
(23) raises the possibility that the observed reduction of galac-
tosyl transferase activity in the GI fraction after treatment with
colchicine derives from a direct effect of Golgi-associated
colchicine on this enzyme activity . Taken together, the above
considerations suggest that colchicine treatment does not sig-
nificantly affect the purity of Golgi fractions from rat liver .
With this consideration in mind we have studied the effect
ofcolchicine on the pattern and extent of uptake of 1251-labeled
oPRL and insulin into Golgi subcellular fractions from rat
liver . In previous studies we have shown that both labeled
peptide hormones are taken up into rat liver by a receptor-
mediated process and concentrated in a relatively intact form
in Golgi fractions (17, 37) . The time course of uptake was
shown to peak first inGh and then later in Gi and GI fractions .
Electron microscope radioautography of Gi and GI fractions
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Fraction (lAg pro-
tein pertube) oPRL
Control
Insulin oPRL
Percent Specific Binding in
1 h
Insulin
colchicine-treated
3 h
oPRL Insulin
Microsomes(150) 7.2±1 .6 10.0±2 .5 8.9±1 .5 9.5±0 .8 11 .9±2 .6 11 .6±1 .7
GI (50) 27.8±2 .7 7.8±0 .7 28.2±2 .6 7.4±1 .8 26.2±9 .5 5.8±1 .4
Gi (50) 24.6±1 .8 9.8±0 .6 42.7±3 .9 18.7±0 .8 31 .9±6 .9 13.8±0 .5
Gh(50) 3.0±1 .8 9.2±1 .0 4.9±3 .7 8.1±2 .6 7.6±1 .2 9.7±1 .4
Plasmalemma (50) 8.1 ± 4.5 24 .6 ± 15 .2 8.1 ± 1 .4 28 .9 ± 1 .7 4.4 ±0.9 26 .1 ±0.1showed that the labeled hormone was associated with bona
fide very low density lipoprotein (VLDL)-filled Golgi vesicles,
predominantly the membranes of these vesicles (17, 38) . Our
present studies have confirmed earlier observations and have
indicated that colchicine treatment inhibits the concentrative
internalization of labeled hormone into the Golgi vesicular
fractions (i.e., GI and Gi elements). This effect was more
marked for l25í-oPRL but was clearly seen for 1251-insulin at 2
min postinjection. The effect on 1251-insulin uptake rapidly
disappeared thereafter in contrast to the more prolonged effect
on 1251-oPRL uptake . Colchicine treatment did not appear to
inhibit uptake of 1251-oPRL into the Gh fraction or association
of
1251-oPRL with the plasmalemma (Fig. 3) or with elements
in the nuclear-mitochondrial cell fraction (Table 11) . In the Gh
fraction, the majority of components containing labeled hor-
mone have been shown to be structures of uncertain origin
which, as we have suggested previously, may be largely endo-
cytotic vesicles (37) . Assuming this, we would tentatively sug-
gest that colchicine has a negligible effect on the early phase of
endocytosis . Rather, colchicine's major action would seem to
be the inhibition of later processes leading to the transfer of
1251-oPRL into Golgi vesicles . As noted in Table VI the radio-
labeled materialfrom subcellularfractions ofcolchicine-treated
rats was comparable in integrity to that from subcellular frac-
tions of control rats.
In previous studies it was shown that colchicine administra-
tion (0.5-25 pmol/100 g body wt) caused an inhibition of
hepatic protein synthesis (40) . Since cycloheximide treatment
of rats resulted in a rapid decrease in hepatic lactogen receptors
levels (18), we considered whether the inhibition of 1251-oPRL
uptake into GI and Gi fractions reflected a depletion of lacto-
gen receptor in these fractions secondary to an inhibition of
protein synthesis. The data ofTable VII indicate that colchicine
treatment did not reduce lactogen or insulin binding levels at
either 1 or 3 h after treatment in any ofthe subcellular fractions .
Previous studies have demonstrated that colchicine inhibits
secretion in a number of tissues including the fl-cell of the
pancreas (20), thyroid (47), anterior pituitary (31), parotid (30),
lacrimal glands (11), hypothalamus (15), and the liver (10) . In
this latter organ, colchicine has been shown to inhibit the
release ofVLDL (41), albumin, and other plasmaproteins (39) .
The studies ofRedman et al. (39) demonstrated that colchicine
inhibited the discharge step leading to the accumulation of
secretory proteins in all Golgi elements. If, as we have suggested
above, the uptake of 1251-oPRL into the Gh fraction reflects
endocytosis, then the failure ofcolchicine to inhibit this uptake
would indicate that receptor-mediated endocytosis is not cou-
pled to exocytosis under the conditions ofour experiment . This
could reflect an influence ofcolchicine to uncouple endocytosis
from exocytosis which may be otherwise coupled processes as
previously suggested (28). In addition to inhibiting mitosis and
secretion, colchicine has been observed to inhibit various cel-
lular uptake processes. Endocytosis of horseradish peroxidase
by chick chondrocytes (33) and rat peritoneal macrophages
(44) was inhibited by colchicine . The drug was shown to inhibit
amino acid and fucose uptake by transplanted Morris hepa-
toma cells (42). Effects distal to the uptake process as such
have been reported. Thus, colchicine has been shown to inhibit
epidermal growth factor (EGF) degradation by 3T3 cells with-
out affecting EGF binding and uptake by these cells (9), and
to inhibit both the endocytosis and subsequent degradation of
sulfated proteoglycans by cultured human skin fibroblasts (45) .
Colchicine inhibited the degradation of chylomicron choles-
teryl ester after uptake by hepatocytes in monolayer (13) . The
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drug has been shown to decrease asialoglycoprotein uptake by
hepatocytes and to impede the access of endocytosed material
to lysosomes (19) . Finally, it has been shown that colchicine
inhibited insulin degradation by hepatocytes at doses of the
drug which had no effect on insulin binding (43) .
These latter observations suggest that the translocation of
internalized substances to intracellular degrading sites has been
retarded by colchicine . Since we have observed an apparent
inhibition by colchicine of the translocation of internalized
peptide hormone to Golgi vesicles, it might be argued that the
endocytotic route leading to ultimate degradation passes
through Golgi vesicular elements. In support of this are our
observations ofa chloroquine-induced retention ofinternalized
1251-insulin in liver with marked accumulation of intact hor-
mone in Golgi elements (36) .
The mechanism of colchicine's inhibitory effect on intracel-
lular translocation is not clear . Since colchicine binds to micro-
tubules and promotes their disaggregation (26), one is tempted
to suggest that such translocations may be regulated by micro-
tubules and hence subject to inhibition by colchicine. In sup-
port of this is our observation that a second microtubular agent,
vincristine, inhibited 1251-oPRL uptake, whereas lumicolchi-
cine, a colchicine congener inactive on microtubule aggregation
(26), was without inhibitory action . On the other hand,Redman
et al . (39) reported seeing microtubulas in the Golgi region of
hepatocytes from rats treated with doses of colchicine compa-
rable to those used in our study. Consideration should also be
given to a possible direct effect of colchicine on membranes
and their topography . Colchicine impaired the movement of
membrane particles in the alveolar membrane of Tetrahymena
pyriformis (49) and bound to rat liver Golgi membranes and
increased their fluidity (23) . Such effects might explain the
influence of colchicine in inhibiting the selective uptake of
concanavalin A binding sites during phagocytosis by polymor-
phonuclear leukocytes (27), concanavalin A-induced aggluti-
nation of hepatoma cells (24), and the appearance of aug-
mented amino acid transport capacity after partial hepatectomy
(46), although an influence via microtubular effects cannot be
excluded. It is possible that colchicine binds to intracellular
membranes and alters their physical properties so as to reduce
the intracellular translocation ofpeptide hormones. The extent
of such inhibition may depend on subtle features of receptor
structure and could then vary from one receptor to another.
This might explain the differences we observed between col-
chicine's inhibition of prolactin and insulin uptake into Golgi
vesicles .
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